Elsevier

Respiratory Medicine

Volume 105, Issue 12, December 2011, Pages 1917-1924
Respiratory Medicine

Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis

https://doi.org/10.1016/j.rmed.2011.08.012Get rights and content
Under an Elsevier user license
open archive

Summary

Background

Establishing inflammatory activity in sarcoidosis patients with persistent disabling symptoms is important. Whole body F18-FDG PET/CT (PET) appeared to be a sensitive method to detect inflammatory activity in newly diagnosed symptomatic sarcoidosis. The aim was to assess the presence of inflammatory activity using PET in sarcoidosis patients with unexplained persistent disabling symptoms and the association between PET findings and serological inflammatory markers.

Methods

Sarcoidosis patients who underwent a PET between June 2005 and June 2010 (n = 89), were retrospectively included. All PET scans were examined and positive findings were classified as thoracic and/or extrathoracic. As serological markers of inflammatory activity angiotensine-converting enzyme (ACE), soluble interleukin-2 receptor (sIL-2R), and neopterine were considered.

Results

In 65/89 (73%) of the studied patients PET was positive, 52 of them (80%) had serological signs of inflammatory activity. In 14/15 patients with a Chest X-ray stage IV PET was positive. In 80% of the PET positive patients extrathoracic inflammatory activity was found. Sensitivity of combined serological inflammatory markers for the presence of inflammatory activity as detected by PET was 80%, specificity 100%, positive predictive value 100%, negative predictive value 65%.

Conclusions

The majority of sarcoidosis patients with persistent disabling symptoms, even those with radiological stage IV, had PET positive findings with remarkably 80% extrathoracic lesions. In 20% PET was positive without signs of serological inflammatory activity. PET appeared to be of additional value to assess inflammatory activity in patients with persistent symptoms in the absence of signs of serological inflammatory activity and to detect extrathoracic lesions.

Keywords

Fluorine18-Fluorodeoxyglucose (F18-FDG)
Inflammation
Positron emission tomography/Computed tomography (PET/CT)
Sarcoidosis
Soluble interleukin-2 receptor

Cited by (0)